EJC Paediatric Oncology
Издатель: Elsevier · ISSN 2772-610X · 55 статей
- Marketing authorisations with limited clinical evidence: A review of small-scale cancer drug studies
- A phase II trial of intrathecal liposomal cytarabine and chemoimmunotherapy with high-dose methotrexate in children, adolescents and young adults with de-novo mature B-NHL
- A systematic review of treatments for paediatric patients with relapsed/refractory mature B-cell Non-Hodgkin lymphoma
- Access to innovative therapies outside clinical trials in pediatric oncology: a national real-world analysis of off-label and compassionate use of targeted therapies and immunotherapies
- MicroOrganoSphere™ technology to advance drug screening in neuroblastoma precision medicine
- Patient-derived organoid in vitro models for antibody-based immunotherapy in pediatric solid tumors
- European standard clinical practice recommendations for children and adolescents with non-rhabdomyosarcoma and other rare soft tissue neoplasms: A joint EPSSG and ERN PaedCan project
- Isotretinoin-induced pseudotumour cerebri in paediatric neuroblastoma
- Ewing’s sarcoma of the head and neck: Outcomes of 102 patients treated at a tertiary cancer centre
- Scalp segmentation and permanent alopecia prediction in pediatric craniospinal irradiation: The PAST and HOPE projects
- Brachytherapy for localized rhabdomyosarcoma: results from the European paediatric soft tissue sarcoma study group RMS2005 trial
- Evaluation of treatment outcomes for wilms tumor in children of Viet Nam using a chemotherapy-surgery strategy: Research in a low- and mid-income country
- Early and long-term patency of inferior vena cava patch reconstruction in children with renal tumour thrombus
- Moesin contributes to the unfavourable prognosis of glioblastoma multiforme possibly by modulating the immune checkpoint molecule B7-H3
- Methodological resources to guide the collection of health-related quality of life data in paediatric cancer clinical trials: Scoping review
- Use of antidepressant drugs, alone or in combination with other psychotropic drugs, among five-year childhood cancer survivors in a Nordic setting: A register-based cohort study from the SALiCCS research programme
- Paediatric oncology meets palliative care: A road towards a common language
- Associations between motor performance, gait characteristics, and gait variability in pediatric oncology: a cross-sectional correlation study
- Identifying gaps and needs in education and career support programs for childhood, adolescent, and young adult cancer survivors: An EU-CAYAS-NET focus group study
- Body image issues among adolescents and young adult cancer patients and survivors – A literature review from the STRONG AYA Project
- The insurance, legal, and financial situation of parents of childhood and adolescent cancer survivors: A systematic review
- Longitudinal neuropsychological outcomes after pediatric non-CNS cancer diagnosis and the role of neurological complications
- Social support experiences and unmet needs of grandparents following a grandchild’s cancer diagnosis: A two-year longitudinal mixed-methods study (The GROkids project)
- Integrating non-clinical and clinical evidence for prioritisation in paediatric oncology drug development: Regulatory experience with three PARP inhibitors
- Translating non-clinical proof-of-concept data into paediatric development decisions: the case of HER2-targeting antibody-drug conjugates